9/10/2015Antitrust in China's Pharma Sector - Bengbu Action Following Big-bang ...

9/9/2015MOFCOM Advocates Prescription Information Sharing with Drug Retailers

9/9/2015Recent Executive Moves

9/7/2015China Sets Its Sights on Life Science

9/6/2015Guizhou Taibang Bio To Source Raw Plasma from Xinjiang Deyuan

9/3/2015Protection Of The Chinese Equivalent For Its English Trademark

9/3/2015China: First PRC Stem Cell Clinical Research Rule

9/2/2015Incyte Licenses Ex-China Rights of Novel mAb from Hengrui

9/2/2015State Council Mandates Trial of Tiered Medical Service System This Yea...

9/2/2015MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For...

9/1/2015Financial-related Local Company News in Brief

9/1/2015Revenues and Net Profits of Listed Chinese Pharma Companies Down in H1...

8/31/2015China's Online Healthcare and Telemedicine Growth Driven by Wearable D...

8/31/2015Chinese Western Medicine Foreign Trade Growth Fell Sharply

8/31/2015Data Snapshot: Performance and R&D Investment of Listed Chines...

8/31/2015NDRC Orders Local Health Authorities in Anhui to Correct Monopolistic ...

8/31/2015Tigermed, Hepalink Jointly Set Up New Drug Investment Fund

8/31/2015CFDA Announces Outcome of Clinical Trial Self-Inspection

8/28/2015Chinese Pharma Growth Down But Still Impressive in H1/2015

8/28/2015Wuxi PharmaTech's CMO Business Gains First GMP Certification from Japa...

8/28/2015CFDA to Withdraw from GMP Certification and Expand Reform

8/27/2015CFDA Terminates Imports of Three Imported Drugs Due To Technical Flaws

8/27/2015Transgenomic Adds New Distributors in China and Japan

8/27/2015Cardiome, Eddingpharm Enter China License & Distribution Agreement...

8/26/2015CFDA Lays Out Plan for Drug Evaluation and Approval System Reform

8/26/2015Wuxi PharmaTech, Lee's Pharma Enter Exclusive Pact for Lab Testing

8/26/2015Shanghai Pharma, CSPC Report Continued Surging Performance in H1

8/26/2015Janssen Terminates R&D Parntership with Hutchinsin Medipharma for ...

8/26/2015Hepalink Acquires Cytovance Biologics

8/26/2015Zhejiang Jingxin Pharma Acquires Majority Stake in US-based CRO

Page:225/361 Total number of articles:10805: [First][<<] [223] [224] [225] [226] [227] [>>] [End]